Dr Jacob Adashek speaks to ecancer about his work involving genomic alterations and immune regulatory molecule expression patterns.

He comments on trends in strategies of cancer care around using combinations of targeted and immune therapies, and highlights the importance of being able to predict the outcomes of these therapies.